Screener
Eligibility screening
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
11 US sites in CA, FL, IL, LA +6
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.